Farallon Capital Management LLC Has $29.55 Million Stock Holdings in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)

Farallon Capital Management LLC decreased its holdings in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) by 2.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 325,000 shares of the company’s stock after selling 7,000 shares during the […]

Related Keywords

China ,Carter Bir ,Manmeet Singh Soni ,Robertw Baird ,Leerink Partnrs ,China Universal Asset Management Co ,Reata Pharmaceuticals Company Profile ,Advisor Group Holdings Inc ,Nisa Investment Advisors ,Jefferies Financial Group ,News Ratings For Reata Pharmaceuticals Daily ,Securities Exchange Commission ,Insider Activity At Reata Pharmaceuticals ,Reata Pharmaceuticals ,Us Bancorp ,Exchange Commission ,Reata Pharmaceuticals Price Performance ,Quarter For Reata Pharmaceuticals ,Nasdaq ,International Assets Investment Management ,Reata Pharmaceuticals Inc ,Farallon Capital Management ,Free Report ,Capital Management ,Assets Investment Management ,Universal Asset Management ,Group Holdings ,Investment Advisors ,Financial Group ,Get Free Report ,Singh Soni ,Dawn Carter Bir ,Reata Pharmaceuticals Daily ,Nasdaq Reta ,Greta ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,